Tech Company Financing Transactions
ALTATHERA Pharmaceuticals Funding Round
Matter participated in a Seed capital raise for ALTATHERA Pharmaceuticals. The financing was announced on 10/28/2014.
Transaction Overview
Company Name
Announced On
10/28/2014
Transaction Type
Accelerator
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
The company will use the proceeds to accelerate its initial development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 South Wacker Dr. 3100
Chicago, IL 60606
USA
Chicago, IL 60606
USA
Phone
Website
Email Address
Not Recorded
Overview
AltaThera Pharmaceuticals is a specialty pharmaceutical company focused on critical care and alternative therapeutics for unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jodi Devlin
Chief Financial Officer
James Scully
General Manager
John Ellis
VP - Bus. Development
Brandon Kashfian
VP - General Counsel
Stephen O'Sullivan
VP - Regulatory Affairs
John Somberg
VP - Sales
Scott Gaito
Browse more venture capital transactions:
Prev: 10/28/2014: MightySignal venture capital transaction
Next: 10/29/2014: GTxcel venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs